摘要
补充和替代疗法(CAM)被定义为目前没有被认定为传统医疗实践的治疗方法。当用作传统疗法的补充时被称为“补充”,用作传统疗法的替代时被称为“替代”。CAM包括许多不同的实践,例如印度韦达养生学、针灸或传统中药(TCM)、植物疗法、顺势疗法、益生菌和膳食补充剂。尽管已有一些有利证据存在证明以上大多数的治疗方法,,但这些疗法的疗效和安全性仍没有被设计良好的科学研究所证实。然而,IBD患者的中的补充和替代疗法的使用很常见,医生也经常面对如何使用他们的问题。因为大多数报道的研究包含方法学难题,医生通常难以充分告知患者。不过,CAM的广泛使用需要被认可。一些疗法因在IBD患者中发挥合理的生物学效应而值得进一步调查。IBD中的对照实验能保证CAM的疗效和安全。本文旨在简要概述当前在IBD患者中使用的各种补充和替代疗法。
关键词: 印度韦达养生学,补充疗法,炎症性肠道疾病,磷脂酰胆碱,益生菌,传统中药
Current Drug Targets
Title:Complementary Therapies in Inflammatory Bowel Diseases
Volume: 15 Issue: 11
Author(s): Philip Esters and Axel Dignass
Affiliation:
关键词: 印度韦达养生学,补充疗法,炎症性肠道疾病,磷脂酰胆碱,益生菌,传统中药
摘要: Complementary and alternative therapies (CAM) are defined as therapies that are presently not considered part of conventional medical practice. They are termed “complementary” when used in addition to conventional therapies and termed “alternative” when used instead of conventional therapies. CAM includes many different practices, for example Ayurveda, acupuncture or traditional Chinese medicine (TCM), phytotherapy, homeopathy, probiotics and dietary supplements. While some evidence of benefit exists regarding some therapies, for most of these therapeutic approaches, the therapeutic efficacy and safety have not been proven in well-designed scientific studies. However, the use of complementary and alternative medicine among IBD patients is common, and physicians are frequently confronted with questions about their use. As most of the reported studies contain methodological problems, it is often difficult for physicians to inform their patients adequately. Nevertheless, the widespread use of CAM needs to be recognized. Some of these agents exert plausible biological effects in IBD patients and warrant further investigation. Controlled trials in IBD are warranted to show therapeutic benefits and safety of CAM. This review aims to give a brief overview on the current use of various complementary and alternative treatment options in IBD patients.
Export Options
About this article
Cite this article as:
Esters Philip and Dignass Axel, Complementary Therapies in Inflammatory Bowel Diseases, Current Drug Targets 2014; 15 (11) . https://dx.doi.org/10.2174/1389450115666140903112802
DOI https://dx.doi.org/10.2174/1389450115666140903112802 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot topic: Infective Endocarditis (Guest Editor: Ioannis Starakis)]
Infectious Disorders - Drug Targets Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued) Stem Cells and Congenital Heart Disease: The Future Potential Clinical Therapy Beyond Current Treatment
Current Cardiology Reviews Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery Contrast Media in Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Prevention of Microbial Communities: Novel Approaches Based Natural Products
Current Pharmaceutical Biotechnology Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives
Medicinal Chemistry Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Prospective Evaluation of the Dosing Regimen of Vancomycin in Children of Different Weight Categories
Current Drug Safety The Cancer Related Thrombotic Tendency in Sepsis
Current Drug Targets Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews Endophthalmitis
Anti-Infective Agents in Medicinal Chemistry Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications
Current Protein & Peptide Science Allergic Bronchopulmonary Aspergillosis: AllA Radiologist Needs To Know
Current Pediatric Reviews LC-MS for Simultaneous Determination of Vancomycin and Teicoplanin in Patient Plasma and its Application to Therapeutic Drug Monitoring
Current Pharmaceutical Analysis Oral Infection and Vascular Disease
Vascular Disease Prevention (Discontinued) Novel Strategies for Combating Pathogenic Biofilms Using Plant Products and Microbial Antibiosis
Current Pharmaceutical Biotechnology Staphylococcus aureus: The Toxic Presence of a Pathogen Extraordinaire
Current Medicinal Chemistry